Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 57 entries
Sorted by: Best Match Show Resources per page
A rare cause of persistent fever in pulmonary homograft endocarditis.

Heart Asia

Spagnoli V, Attias D, Vahanian A.
PMID: 27326137
Heart Asia. 2013 Oct 10;5(1):225. doi: 10.1136/heartasia-2013-010414. eCollection 2013.

No abstract available.

Cite
Spagnoli V, Attias D, Vahanian A. A rare cause of persistent fever in pulmonary homograft endocarditis. Heart Asia. 2013;5(1):225doi: 10.1136/heartasia-2013-010414.
Spagnoli, V., Attias, D., & Vahanian, A. (2013). A rare cause of persistent fever in pulmonary homograft endocarditis. Heart Asia, 5(1), 225. https://doi.org/10.1136/heartasia-2013-010414
Spagnoli, Vincent, et al. "A rare cause of persistent fever in pulmonary homograft endocarditis." Heart Asia vol. 5,1 (2013): 225. doi: https://doi.org/10.1136/heartasia-2013-010414
Spagnoli V, Attias D, Vahanian A. A rare cause of persistent fever in pulmonary homograft endocarditis. Heart Asia. 2013 Oct 10;5(1):225. doi: 10.1136/heartasia-2013-010414. eCollection 2013. PMID: 27326137; PMCID: PMC4832757.
Copy Download .nbib Format: NLM
Combination immunotherapy for high-risk resected and metastatic melanoma patients.

The Ochsner journal

Riker AI, Rossi GR, Masih P, Alsfeld LC, Denham F, Tennant L, Ramsey WJ, Vahanian NN, Link CJ.
PMID: 24940124
Ochsner J. 2014;14(2):164-74.

BACKGROUND: Patients with advanced melanoma have a poor outcome. We hypothesize that combination immunotherapy can synergistically activate host immunity to generate an effective treatment for patients with high-risk, resected stage 3, recurrent, refractory, or stage 4 melanoma.METHODS: We conducted...

Cite
Riker AI, Rossi GR, Masih P, et al. Combination immunotherapy for high-risk resected and metastatic melanoma patients. Ochsner J. 2014;14(2):164-74
Riker, A. I., Rossi, G. R., Masih, P., Alsfeld, L. C., Denham, F., Tennant, L., Ramsey, W. J., Vahanian, N. N., & Link, C. J. (2014). Combination immunotherapy for high-risk resected and metastatic melanoma patients. The Ochsner journal, 14(2), 164-74.
Riker, Adam I, et al. "Combination immunotherapy for high-risk resected and metastatic melanoma patients." The Ochsner journal vol. 14,2 (2014): 164-74.
Riker AI, Rossi GR, Masih P, Alsfeld LC, Denham F, Tennant L, Ramsey WJ, Vahanian NN, Link CJ. Combination immunotherapy for high-risk resected and metastatic melanoma patients. Ochsner J. 2014;14(2):164-74. PMID: 24940124; PMCID: PMC4052581.
Copy Download .nbib Format: NLM
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan.

Oncoimmunology

Metz R, Rust S, Duhadaway JB, Mautino MR, Munn DH, Vahanian NN, Link CJ, Prendergast GC.
PMID: 23264892
Oncoimmunology. 2012 Dec 01;1(9):1460-1468. doi: 10.4161/onci.21716.

Tryptophan catabolism by indoleamine 2,3-dioxygenase (IDO) alters inflammation and favors T-cell tolerance in cancer, but the underlying molecular mechanisms remain poorly understood. The integrated stress response kinase GCN2, a sensor of uncharged tRNA that is activated by amino acid...

Cite
Metz R, Rust S, Duhadaway JB, et al. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. Oncoimmunology. 2012;1(9):1460-1468doi: 10.4161/onci.21716.
Metz, R., Rust, S., Duhadaway, J. B., Mautino, M. R., Munn, D. H., Vahanian, N. N., Link, C. J., & Prendergast, G. C. (2012). IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. Oncoimmunology, 1(9), 1460-1468. https://doi.org/10.4161/onci.21716
Metz, Richard, et al. "IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan." Oncoimmunology vol. 1,9 (2012): 1460-1468. doi: https://doi.org/10.4161/onci.21716
Metz R, Rust S, Duhadaway JB, Mautino MR, Munn DH, Vahanian NN, Link CJ, Prendergast GC. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. Oncoimmunology. 2012 Dec 01;1(9):1460-1468. doi: 10.4161/onci.21716. PMID: 23264892; PMCID: PMC3525601.
Copy Download .nbib Format: NLM
Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries.

Journal of European CME

Murray S, Carrera C, Lazure P, Vardas P, Zamorano JL, Kearney P, Goncalves L, Fox K, Vahanian A.
PMID: 29644134
J Eur CME. 2017 Jun 22;6(1):1337478. doi: 10.1080/21614083.2017.1337478. eCollection 2017.

No abstract available.

Cite
Murray S, Carrera C, Lazure P, et al. Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries. J Eur CME. 2017;6(1):1337478doi: 10.1080/21614083.2017.1337478.
Murray, S., Carrera, C., Lazure, P., Vardas, P., Zamorano, J. L., Kearney, P., Goncalves, L., Fox, K., & Vahanian, A. (2017). Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries. Journal of European CME, 6(1), 1337478. https://doi.org/10.1080/21614083.2017.1337478
Murray, S, et al. "Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries." Journal of European CME vol. 6,1 (2017): 1337478. doi: https://doi.org/10.1080/21614083.2017.1337478
Murray S, Carrera C, Lazure P, Vardas P, Zamorano JL, Kearney P, Goncalves L, Fox K, Vahanian A. Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries. J Eur CME. 2017 Jun 22;6(1):1337478. doi: 10.1080/21614083.2017.1337478. eCollection 2017. PMID: 29644134; PMCID: PMC5843045.
Copy Download .nbib Format: NLM
The year in cardiology 2017: valvular heart disease.

European heart journal

Søndergaard L, Saraste A, Christersson C, Vahanian A.
PMID: 29300877
Eur Heart J. 2018 Feb 21;39(8):650-657. doi: 10.1093/eurheartj/ehx772.

No abstract available.

Cite
Søndergaard L, Saraste A, Christersson C, et al. The year in cardiology 2017: valvular heart disease. Eur Heart J. 2018;39(8):650-657doi: 10.1093/eurheartj/ehx772.
Søndergaard, L., Saraste, A., Christersson, C., & Vahanian, A. (2018). The year in cardiology 2017: valvular heart disease. European heart journal, 39(8), 650-657. https://doi.org/10.1093/eurheartj/ehx772
Søndergaard, Lars, et al. "The year in cardiology 2017: valvular heart disease." European heart journal vol. 39,8 (2018): 650-657. doi: https://doi.org/10.1093/eurheartj/ehx772
Søndergaard L, Saraste A, Christersson C, Vahanian A. The year in cardiology 2017: valvular heart disease. Eur Heart J. 2018 Feb 21;39(8):650-657. doi: 10.1093/eurheartj/ehx772. PMID: 29300877.
Copy Download .nbib Format: NLM
Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial.

Archives of cardiovascular diseases

Capelle A, Obadia JF, Iung B, Messika-Zeitoun D, Vahanian A, Guerin P, Lefèvre T, Bonnet G, Donal E, Leurent G, Trochu JN, Armoiry X.
PMID: 34802961
Arch Cardiovasc Dis. 2021 Dec;114(12):805-813. doi: 10.1016/j.acvd.2021.10.005. Epub 2021 Nov 19.

BACKGROUND: Percutaneous mitral valve repair (pMVR) is reimbursed in France for severe secondary mitral regurgitation (SMR), but French data regarding the hospitalization index stay are lacking.AIMS: Our objectives were to describe the index hospitalization stay and to evaluate the...

Cite
Capelle A, Obadia JF, Iung B, et al. Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial. Arch Cardiovasc Dis. 2021;114(12):805-813doi: 10.1016/j.acvd.2021.10.005.
Capelle, A., Obadia, J. F., Iung, B., Messika-Zeitoun, D., Vahanian, A., Guerin, P., Lefèvre, T., Bonnet, G., Donal, E., Leurent, G., Trochu, J. N., & Armoiry, X. (2021). Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial. Archives of cardiovascular diseases, 114(12), 805-813. https://doi.org/10.1016/j.acvd.2021.10.005
Capelle, Aude, et al. "Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial." Archives of cardiovascular diseases vol. 114,12 (2021): 805-813. doi: https://doi.org/10.1016/j.acvd.2021.10.005
Capelle A, Obadia JF, Iung B, Messika-Zeitoun D, Vahanian A, Guerin P, Lefèvre T, Bonnet G, Donal E, Leurent G, Trochu JN, Armoiry X. Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial. Arch Cardiovasc Dis. 2021 Dec;114(12):805-813. doi: 10.1016/j.acvd.2021.10.005. Epub 2021 Nov 19. PMID: 34802961.
Copy Download .nbib Format: NLM
2021 ESC/EACTS Guidelines for the management of valvular heart disease.

European heart journal

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W.
PMID: 34453165
Eur Heart J. 2021 Aug 28; doi: 10.1093/eurheartj/ehab395. Epub 2021 Aug 28.

No abstract available.

Cite
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab395.
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., Delgado, V., Freemantle, N., Gilard, M., Haugaa, K. H., Jeppsson, A., Jüni, P., Pierard, L., Prendergast, B. D., Sádaba, J. R., Tribouilloy, C., Wojakowski, W. (2021). 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European heart journal, . https://doi.org/10.1093/eurheartj/ehab395
Vahanian, Alec, et al. "2021 ESC/EACTS Guidelines for the management of valvular heart disease." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab395
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021 Aug 28; doi: 10.1093/eurheartj/ehab395. Epub 2021 Aug 28. PMID: 34453165.
Copy Download .nbib Format: NLM
Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study.

World journal of plastic surgery

Alemrajabi M, Khavanin Zadeh M, Hemmati N, Banivaheb B, Alemrajabi F, Jahanian S, Bahadoram M, Barahman M.
PMID: 34912674
World J Plast Surg. 2021 Sep;10(3):104-110. doi: 10.29252/wjps.10.3.104.

BACKGROUND: The standard surgical treatment for low rectal cancer is abdominoperineal resection (APR). Comparing to primary closure, immediate flap reconstruction has shown to have good outcomes. We aimed to assess the inferior rectus abdominis muscle flap complications after APR...

Cite
Alemrajabi M, Khavanin Zadeh M, Hemmati N, et al. Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study. World J Plast Surg. 2021;10(3):104-110doi: 10.29252/wjps.10.3.104.
Alemrajabi, M., Khavanin Zadeh, M., Hemmati, N., Banivaheb, B., Alemrajabi, F., Jahanian, S., Bahadoram, M., & Barahman, M. (2021). Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study. World journal of plastic surgery, 10(3), 104-110. https://doi.org/10.29252/wjps.10.3.104
Alemrajabi, Mahdi, et al. "Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study." World journal of plastic surgery vol. 10,3 (2021): 104-110. doi: https://doi.org/10.29252/wjps.10.3.104
Alemrajabi M, Khavanin Zadeh M, Hemmati N, Banivaheb B, Alemrajabi F, Jahanian S, Bahadoram M, Barahman M. Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study. World J Plast Surg. 2021 Sep;10(3):104-110. doi: 10.29252/wjps.10.3.104. PMID: 34912674; PMCID: PMC8662682.
Copy Download .nbib Format: NLM
Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study.

World journal of plastic surgery

Alemrajabi M, Khavanin Zadeh M, Hemmati N, Banivaheb B, Alemrajabi F, Jahanian S, Bahadoram M, Barahman M.
PMID: 34912674
World J Plast Surg. 2021 Sep;10(3):104-110. doi: 10.29252/wjps.10.3.104.

BACKGROUND: The standard surgical treatment for low rectal cancer is abdominoperineal resection (APR). Comparing to primary closure, immediate flap reconstruction has shown to have good outcomes. We aimed to assess the inferior rectus abdominis muscle flap complications after APR...

Cite
Alemrajabi M, Khavanin Zadeh M, Hemmati N, et al. Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study. World J Plast Surg. 2021;10(3):104-110doi: 10.29252/wjps.10.3.104.
Alemrajabi, M., Khavanin Zadeh, M., Hemmati, N., Banivaheb, B., Alemrajabi, F., Jahanian, S., Bahadoram, M., & Barahman, M. (2021). Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study. World journal of plastic surgery, 10(3), 104-110. https://doi.org/10.29252/wjps.10.3.104
Alemrajabi, Mahdi, et al. "Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study." World journal of plastic surgery vol. 10,3 (2021): 104-110. doi: https://doi.org/10.29252/wjps.10.3.104
Alemrajabi M, Khavanin Zadeh M, Hemmati N, Banivaheb B, Alemrajabi F, Jahanian S, Bahadoram M, Barahman M. Inferior Part of Rectus Abdominis Muscle Flap Outcomes after Abdominoperineal Resection: A Case Series Pilot Study. World J Plast Surg. 2021 Sep;10(3):104-110. doi: 10.29252/wjps.10.3.104. PMID: 34912674; PMCID: PMC8662682.
Copy Download .nbib Format: NLM
2021 ESC/EACTS Guidelines for the management of valvular heart disease.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W.
PMID: 34931612
EuroIntervention. 2021 Dec 22; doi: 10.4244/EIJ-E-21-00009. Epub 2021 Dec 22.

No abstract available.

Cite
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention. 2021;doi: 10.4244/EIJ-E-21-00009.
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., Delgado, V., Freemantle, N., Haugaa, K. H., Jeppsson, A., Jüni, P., Pierard, L., Prendergast, B. D., Sádaba, J. R., Tribouilloy, C., & Wojakowski, W. (2021). 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, . https://doi.org/10.4244/EIJ-E-21-00009
Vahanian, Alec, et al. "2021 ESC/EACTS Guidelines for the management of valvular heart disease." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. (2021). doi: https://doi.org/10.4244/EIJ-E-21-00009
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention. 2021 Dec 22; doi: 10.4244/EIJ-E-21-00009. Epub 2021 Dec 22. PMID: 34931612.
Copy Download .nbib Format: NLM
Inferior part of rectus abdominis muscle flap: A case report.

Medical journal of the Islamic Republic of Iran

Alemrajabi M, Moradi S, Jahanian S, Banivaheb B, Hemmati N, Safari S.
PMID: 32002390
Med J Islam Repub Iran. 2019 Oct 16;33:111. doi: 10.34171/mjiri.33.111. eCollection 2019.

No abstract available.

Cite
Alemrajabi M, Moradi S, Jahanian S, et al. Inferior part of rectus abdominis muscle flap: A case report. Med J Islam Repub Iran. 2019;33:111doi: 10.34171/mjiri.33.111.
Alemrajabi, M., Moradi, S., Jahanian, S., Banivaheb, B., Hemmati, N., & Safari, S. (2019). Inferior part of rectus abdominis muscle flap: A case report. Medical journal of the Islamic Republic of Iran, 33111. https://doi.org/10.34171/mjiri.33.111
Alemrajabi, Mahdi, et al. "Inferior part of rectus abdominis muscle flap: A case report." Medical journal of the Islamic Republic of Iran vol. 33 (2019): 111. doi: https://doi.org/10.34171/mjiri.33.111
Alemrajabi M, Moradi S, Jahanian S, Banivaheb B, Hemmati N, Safari S. Inferior part of rectus abdominis muscle flap: A case report. Med J Islam Repub Iran. 2019 Oct 16;33:111. doi: 10.34171/mjiri.33.111. eCollection 2019. PMID: 32002390; PMCID: PMC6983492.
Copy Download .nbib Format: NLM
The effect of blended training on the quality of life of children with nephrotic syndrome.

Journal of family medicine and primary care

Khanjari S, Jahanian S, Haghani H.
PMID: 30598934
J Family Med Prim Care. 2018 Sep-Oct;7(5):921-926. doi: 10.4103/jfmpc.jfmpc_176_18.

BACKGROUND: Nephrotic syndrome is a common nephrology disorder in children that can affect the quality of health of children and adolescents significantly. Training children with nephrotic syndrome with special emphasis on the use of blended training can provide new...

Cite
Khanjari S, Jahanian S, Haghani H. The effect of blended training on the quality of life of children with nephrotic syndrome. J Family Med Prim Care. 2018;7(5):921-926doi: 10.4103/jfmpc.jfmpc_176_18.
Khanjari, S., Jahanian, S., & Haghani, H. (2018). The effect of blended training on the quality of life of children with nephrotic syndrome. Journal of family medicine and primary care, 7(5), 921-926. https://doi.org/10.4103/jfmpc.jfmpc_176_18
Khanjari, Sedighe, et al. "The effect of blended training on the quality of life of children with nephrotic syndrome." Journal of family medicine and primary care vol. 7,5 (2018): 921-926. doi: https://doi.org/10.4103/jfmpc.jfmpc_176_18
Khanjari S, Jahanian S, Haghani H. The effect of blended training on the quality of life of children with nephrotic syndrome. J Family Med Prim Care. 2018 Sep-Oct;7(5):921-926. doi: 10.4103/jfmpc.jfmpc_176_18. PMID: 30598934; PMCID: PMC6259550.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 57 entries